The NHS will implement mHealth solution for schizophrenia

The NHS will implement mHealth solution for schizophrenia

Copenhagen, Denmark – 21 June 2016. Monsenso, a Copenhagen-based technology company, announced today that the NHS Foundation Trust of Central Northwest London (CNWL) will implement the Monsenso mobile health (mHealth) solution to support the treatment of young patients suffering from schizophrenia.

The pilot, which will run from July to December, will be implemented amongst young patients aged 18 to 24, across Kensington, Chelsea, Westminster, Milton Keynes, and Hillingdon. It will be the first step prior to rolling out the solution more widely and fully integrating it with TTP SystmOne enabling clinicians to access all patient data from one place.

The objective of the pilot is to evaluate the clinical and economic benefits of using the Monsenso solution such as reducing the number of psychiatric readmissions and using the latest technology to collect and analyse patient data.

With the help of the Monsenso mHealth solution, clinicians will be able to identify the triggers and early warning signs of the young patients and intervene at an early stage to avoid emergency situations. The clinical web portal provides clinicians with an insight into the correlation between a patient’s behavioural patterns and the illness enabling them to provide a more informed and better treatment to a larger number of patients.

Thomas Lethenborg, CEO at Monsenso ApS, said “CNWL aims to offer its patients high-quality treatment with the latest technology available. With the implementation of the Monsenso mHealth solution, clinicians will be able to access a patient’s historical aggregated data, which will help them offer a better treatment based on evidence.”

Dr Pramod Prabhakaran, Divisional Medical Director of CNWL, said “We are working closely with our service users, partners, and stakeholders to be more responsive towards people’s needs. The implementation of the Monsenso mHealth solution is part of a wider service redesign to improve our community mental health services across North West London.”

For additional information about Monsenso contact:

Jennifer Highland
Marketing and Communications Manager
Monsenso
+45 81 71 7713
highland@monsenso.com

For additional information about CNWL contact:

Mike Waddington
Communications Director
CNWL
+44 77 40 42 28 73
mikewaddington@nhs.net

 

About CNWL
Central and North West London NHS Foundation Trust is one of the largest trusts in the UK, caring for people with a wide range of physical and mental health needs. We provide a wide range of services to treat people with a variety of health needs. In broad terms, these include common physical health problems, long-term conditions, mental health, learning disabilities, eating disorders, addictions and sexual health. We are here to provide support for people through every stage of life. The majority of our services are provided in the community, which means treating people in their homes or from clinics close to home. Where community care is not possible we offer a number of facilities to treat people in the hospital or residential environments. We also provide healthcare in prisons in London and the surrounding areas. We are committed to providing services that meet the needs of the people who use them, and we actively encourage involvement from local people who can help make a difference.[/vc_column_text][vc_column_text]You can download this article as PDF in English and Danish